Cytokinetics, Incorporated Cytokinetics, Incorporated

Cytokinetics, Incorporated

CYTK

Rang în acțiuni #2306
Cytokinetics, Incorporated, a biopharmaceutical company, focuses on... Cytokinetics, Incorporated, a biopharmaceutical company, focuses on discovering, developing, and commercializing novel muscle activators and muscle inhibitors as potential treatments for debilitating diseases in the United States. The company markets MYQORZO, a novel, oral, and small molecule cardiac myosin inhibitor for the treatment of symptomatic oHCM. It also develops Aficamten, a novel, oral, and small molecule cardiac myosin inhibitor for the treatment of HCM; and omecamtiv mecarbil, a potential treatment across the continuum of care in heart failure with severely reduced ejection fraction. In addition, the company is involved in developing and Ulacamten, a novel, selective, oral, and small molecule cardiac myosin inhibitor designed to reduce the hypercontractility associated with heart failure with preserved ejection fraction in Phase 1 clinical trials; and CK-089, a fast skeletal muscle troponin activator in Phase 1 clinical trials. Cytokinetics, Incorporated was incorporated in 1997 and is headquartered in South San Francisco, California.
Preț acțiune
$64.24
Capitalizare de piață
$8.93B
Schimbare (1 zi)
2.54%
Schimbare (1 an)
8.24%
Țară
US
Tranzacționează Cytokinetics, Incorporated (CYTK)

Categorie

Healthcare
Istoricul spliturilor pentru Cytokinetics, Incorporated (CYTK)
Acțiunea Cytokinetics, Incorporated (simbol: CYTK) a trecut printr-un total de 1 splituri.
Cel mai recent split a avut loc pe Jun 25, 2013.
O acțiune CYTK cumpărată înainte de Jun 25, 2013 este echivalentă astăzi cu 0.16666666666667 acțiuni CYTK.
Listă splituri acțiuni
An Split Multiplu Multiplu cumulativ
2013-06-25 1:6 x0.16666666666667 x0.16666666666667
Splituri pentru companii similare sau competitori
Companie Număr total de splituri Multiplu cumulativ Țara
1 x2
US
0 -
US
1 x3
AU
0 -
CH
0 -
NL